Aneuploidy, the condition of having an unbalanced chromosome complement that deviates from the normal euploid state, consistently impairs cellular fitness across diverse experimental systems. Studies in haploid yeast have established that aneuploidy causes proliferative disadvantages and cell cycle defects, slowing the orderly progression through cell cycle phases and checkpoints. The mechanistic basis for these fitness costs centers on proteome imbalance: extra chromosome genes drive aneuploid phenotypes through imbalanced protein composition, where the additional gene copies produce excess proteins that overwhelm cellular protein homeostasis systems. This protein burden manifests as heightened sensitivity to protein synthesis interference and protein folding stress, suggesting that aneuploid cells operate closer to the limits of their proteostasis capacity. Interestingly, aneuploid cells display increased glucose uptake, which may represent a compensatory metabolic response to meet the energetic demands of managing excess protein production and maintaining cellular function under chromosomal imbalance. However, several key aspects remain unresolved. The relative contributions of specific gene dosage effects versus general proteotoxic stress in determining the severity of different aneuploid phenotypes are still debated. Additionally, whether the proliferative disadvantage caused by aneuploidy is entirely attributable to protein imbalance or whether other mechanisms such as DNA replication stress, altered stoichiometry of macromolecular complexes, or metabolic rewiring play independent roles remains contentious. The observation that aneuploidy both impairs proliferation and increases glucose uptake raises questions about how metabolic adaptations interface with proteostasis mechanisms in determining overall fitness.
Member Concepts
- cell cycle defects
- cell cycle progression
- chromosome duplication
- euploid
- glucose uptake
- haploid yeast
- phenotype
- proliferative disadvantage
- protein composition
- protein folding
- protein production
- sensitivity
Tensions
- protein composition imbalance vs proliferative disadvantage: While imbalanced protein composition from extra chromosome genes clearly drives aneuploid phenotypes, it remains unclear whether proliferative disadvantage stems entirely from proteotoxic stress or whether aneuploidy causes additional independent fitness costs through mechanisms like DNA replication stress or metabolic burden. Resolving this would require dissecting which fraction of the proliferative defect can be rescued by enhancing proteostasis capacity alone.
- glucose uptake increase vs proliferative disadvantage: Aneuploidy simultaneously increases glucose uptake while causing proliferative disadvantage, creating an apparent paradox where cells consume more energy substrate yet divide more slowly. One interpretation suggests increased glucose uptake compensates for metabolic inefficiency, while another proposes it reflects futile biosynthetic cycling or stress responses. Distinguishing between these requires measuring whether the additional glucose fuels productive biosynthesis or dissipates as metabolic waste.
- extra chromosome gene expression vs phenotype severity: Different aneuploidies cause varying degrees of cell cycle defects and fitness costs, but whether phenotype severity correlates primarily with the number of extra genes, the identity of specific amplified genes, or the magnitude of protein imbalance remains debated. Some evidence suggests gene-specific dosage sensitivity dominates, while other work emphasizes cumulative protein burden. Resolving this requires systematic comparison of aneuploidies with similar gene numbers but different gene identities.
Open Questions
- What fraction of the proliferative disadvantage in aneuploid cells can be attributed to protein imbalance versus other mechanisms such as DNA replication stress or metabolic inefficiency?
- Does the increased glucose uptake in aneuploid cells fuel compensatory protein quality control mechanisms, or does it reflect metabolic reprogramming for other cellular functions?
- Why do certain chromosomes cause more severe cell cycle defects when duplicated, and is this determined by total gene number, specific dosage-sensitive genes, or the degree of protein complex stoichiometry disruption?
- Can enhancing protein folding capacity or degradation pathways fully rescue the cell cycle progression defects caused by aneuploidy?
- How do aneuploid cells balance the energetic costs of increased glucose metabolism with the reduced proliferative capacity and altered cell cycle dynamics?